To include your compound in the COVID-19 Resource Center, submit it here.

FDA to hold workshop on structured benefit-risk assessment

FDA will hold a public workshop on Sept. 18 to discuss the structured assessment of benefit and

Read the full 175 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE